[{"address1": "42 Hayarkon Street", "city": "Yavne", "zip": "8122745", "country": "Israel", "phone": "972 7 797 14100", "fax": "972 7 797 14111", "website": "https://www.mediwound.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.", "fullTimeEmployees": 100, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ofer  Gonen B.Sc.", "age": 50, "title": "Chief Executive Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 649000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hani  Luxenburg", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 235000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yaron  Meyer Adv.", "age": 44, "title": "Executive VP, General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 299000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ety  Klinger MBA, Ph.D.", "age": 61, "title": "Chief Research & Development Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 377000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lior  Rosenberg M.D.", "age": 77, "title": "Co-Founder", "yearBorn": 1946, "fiscalYear": 2023, "totalPay": 727000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shmulik  Hess Ph.D.", "age": 50, "title": "COO & Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liron  Gal", "title": "Executive Director of Manufacturing Science & Technology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Barry J. Wolfenson", "age": 56, "title": "Executive Vice President of Strategy & Corporate Development", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 16.96, "open": 17.635, "dayLow": 16.77, "dayHigh": 17.635, "regularMarketPreviousClose": 16.96, "regularMarketOpen": 17.635, "regularMarketDayLow": 16.77, "regularMarketDayHigh": 17.635, "beta": 0.835, "forwardPE": -7.576576, "volume": 28735, "regularMarketVolume": 28735, "averageVolume": 152195, "averageVolume10days": 41750, "averageDailyVolume10Day": 41750, "bid": 16.6, "ask": 17.09, "bidSize": 100, "askSize": 100, "marketCap": 181427248, "fiftyTwoWeekLow": 7.45, "fiftyTwoWeekHigh": 24.0, "priceToSalesTrailing12Months": 9.007857, "fiftyDayAverage": 17.939, "twoHundredDayAverage": 15.91418, "currency": "USD", "enterpriseValue": 133334760, "profitMargins": -0.99166, "floatShares": 6165793, "sharesOutstanding": 10786400, "sharesShort": 589785, "sharesShortPriorMonth": 638651, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.0547, "heldPercentInsiders": 0.19760999, "heldPercentInstitutions": 0.39878, "shortRatio": 9.8, "shortPercentOfFloat": 0.0639, "impliedSharesOutstanding": 10831100, "bookValue": 1.924, "priceToBook": 8.742204, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -19973000, "trailingEps": -2.16, "forwardEps": -2.22, "pegRatio": -0.06, "lastSplitFactor": "1:7", "lastSplitDate": 1671494400, "enterpriseToRevenue": 6.62, "enterpriseToEbitda": -9.194, "52WeekChange": 0.7612566, "SandP52WeekChange": 0.34083736, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "MDWD", "underlyingSymbol": "MDWD", "shortName": "MediWound Ltd.", "longName": "MediWound Ltd.", "firstTradeDateEpochUtc": 1395322200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "1d731941-74dc-3c53-8065-5808c744e4bc", "messageBoardId": "finmb_1570881", "gmtOffSetMilliseconds": -14400000, "currentPrice": 16.82, "targetHighPrice": 36.0, "targetLowPrice": 25.0, "targetMeanPrice": 29.75, "targetMedianPrice": 29.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 29215000, "totalCashPerShare": 3.146, "ebitda": -14503000, "totalDebt": 6355000, "quickRatio": 1.508, "currentRatio": 1.65, "totalRevenue": 20141000, "debtToEquity": 35.564, "revenuePerShare": 2.18, "returnOnAssets": -0.15769, "returnOnEquity": -0.75658, "freeCashflow": -8423750, "operatingCashflow": -14097000, "revenueGrowth": 0.061, "grossMargins": 0.13252, "ebitdaMargins": -0.72007006, "operatingMargins": -0.88564, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-03"}]